Skip to content The Leeds Teaching Hospitals NHS Trust Website
    

Research & Development Website

Research in Progress

Changes to the Research Team

Research Ethics Committee Requirements

If the Chief Investigator (CI) or local Principal Investigator (PI) is changed, please contact the main REC (i.e. the committee that provided the main ethical review of the study) to establish their requirements for reporting a change to CI or PI.

Changes to the research team other than the CI and PI are not considered substantial changes and do not need to be reported to the REC.

For REC contact details please click here

Back

MHRA Requirements

If the study is a Clinical Trial of an Investigational Medicinal Product, the MHRA as the competent authority under the Clinical Trials Regulations, requires notification of change of Chief Investigator as named on the Clinical Trial Authorisation. Please see the relevant section of the Clinical Trials Toolkit for further information.

Sponsor Requirements

Please inform the Sponsor or changes to the Chief Investigator (CI) or local Principal Investigators (PIs). This will allow the Sponsor to ensure that appropriate agreements, allocating responsibilities for the study can be put in place with the new CI or PI. Where the Trust or the University of Leeds is the Sponsor, please inform the R&D Department of the change.

R&D Requirements

Please notify the R&D Department of any changes to the local Research Team named on the original REC and LTHT R&D Approval application forms. This will allow us to extend NHS indemnity to the new members of the research team.

Please note that honorary contracts may be required for new members of the research team. Please click here for further guidance on honorary contracts

Addition of New Sites to the Study

Clinical Trials of Investigational Medicinal Products:

All other research:

Back

 

Home | Patients | Careers | News | Corporate | Resources | Freedom of Information | Website Help